-The Hindu Business Line The solution lies in better prices for produce, generating non-farm income, and reducing costs of farming After the Yogi Adityanath government waived farm loans of about ?36,000 crore for UP farmers, pressure has mounted on other States to follow suit. But contrary to common belief, debt waivers aside from possibly guaranteeing electoral victory, do little to alleviate the plight of farmers. Neither do they help kick-start the rural...

-The Hindu Two separate decisions on farm loan waivers could have a domino effect Chairing his first cabinet meeting after taking over the reins in Uttar Pradesh, Chief Minister Yogi Adityanath approved a write-off on outstanding farmer loans of up to Rs. 1 lakh taken before March 31, 2016. The State cabinet also decided to waive loans worth Rs. 6,000 crore extended to small and marginal farmers that had turned into non-performing...

-Livemint.com Narendra Modi’s election promise in Uttar Pradesh comes back to haunt as other states demand the Union govt offer an agriculture bailout package across the country New Delhi: An election promise to farmers in the politically sensitive state of Uttar Pradesh is coming back to haunt Prime Minister Narendra Modi, as other states demand the Union government offer an agriculture bailout package across the country. During the hard-fought election campaign, Modi pledged...

-The Hindu Business Line State govt package is inadequate, unfair and not quick enough, says farm sector Chennai: “When there is no water to drink, what can we say about irrigation?” asked K Venkatesan, a farmer near Vridhachalam. Whether canal dependent or bore well irrigated, all crops have withered, he said. Insurance compensation and the disbursement of the State government’s Relief Package have to be expedited, said farmers’ representatives. Farmers have to be fully...

-The Hindu In 2014, an Indian pharmaceutical company was globally the first to receive approval to market a biosimilar, thereby affordable version, of the breast cancer drug Trastuzumab. Almost immediately, Swiss pharmaceutical company Roche, innovator of the drug, filed a suit against the Indian Food & Drug Administration (FDA) to block its sale. The action firmly put their profits ahead of the lives of women with breast cancer. Roche effectively embroiled India’s...